In human skin, the 3895-bp deletion of mitochondrial DNA (mtDNA 3895 ) is catalysed by ultraviolet (UV) light through the generation of reactive oxygen species. Given its function in vision, the human eye is exposed to oxidising UV and blue light in its anterior (cornea, iris) and posterior (retina) structures. In this study, we employed a highly sensitive quantitative PCR technique to determine mtDNA 3895 occurrence in human eye. Our analysis shows that the mtDNA 3895 is concentrated in both the cornea and the retina. Within the cornea, the highest mtDNA 3895 level is found in the stroma, the cellular layer conferring transparency and rigidity to the human cornea. Moreover, mtDNA 3895 accumulates with age in the stroma, suggesting a role of this deletion in corneal ageing. Within the retina, mtDNA 3895 is concentrated in the macular region of both the neural retina and the retinal pigment epithelium, supporting the hypothesis that this deletion is implicated in retinal pathologies such as age-related macular degenerescence. Taken together, our results imply that UV and blue light catalyse mtDNA 3895 induction in the human eye.
Introduction
The human mitochondrial DNA (mtDNA) is a double-stranded 16 569 bp circular DNA. There are up to 10 000 mitochondria per cell and each mitochondrion contains up to 10 mtDNA copies (1) . The presence of many mtDNA copies makes somatic mtDNA mutations heteroplasmic, that is a mixture of wildtype and mutant mtDNA in a given cell. Compared with genomic DNA, mtDNA is highly susceptible to various mutations, such as deletion, frameshift and missense mutations (2, 3) . Many factors are responsible for the high mutation sensitivity of the mtDNA genome. The absence of histones, the limited repair and proofreading capacities during replication by the DNA polymerase γ are among those factors (3) (4) (5) . Another important factor explaining the high sensitivity of mtDNA is its close proximity to the mitochondrial inner membrane where the adenosine triphosphate production through the oxidative phosphorylation (OXPHOS) process takes place. The OXPHOS pathway induces a large amount of reactive oxygen species (ROS) including superoxide anion, hydrogen peroxide and hydroxyl radical (6) (7) (8) (9) that lead to the formation of oxidatively generated mutagenic DNA damage (10) . ROS can also be exogenously generated, primarily by solar ultraviolet (UV) (100-400 nm) and blue light (400-500 nm). More precisely, through a photodynamic process, UV and blue light photoexcite cellular chromophores, leading to ROS production and ultimately to DNA damage formation (11) .
Among all mutations found in the mtDNA genome, there are more than 263 known deletions (12) . Because they are frequently detected in aged tissues with high-energy demands, it has been suggested that mtDNA deletions are related to ageing (13) (14) (15) (16) (17) . A vicious cycle has been hypothesised to explain how mtDNA deletions can translate into ageing and vice versa. Oxidative stress induces mtDNA deletion mutations that lead to a deficient mitochondrial respiratory chain, which in turn conduces to reduced energy production, to increased ROS production and, ultimately, to tissue ageing (18, 19) . The oxidative stress catalysing the vicious cycle can be endogenous (OXPHOS process) or exogenous (e.g. exposition to solar UV and blue rays) (10, 20) . The exact molecular mechanism explaining mtDNA deletion formation is not entirely understood. However, most mtDNA deletions are flanked by perfect (68%) or imperfect (12%) repeated DNA sequences and a defect in oxidatively generated DNA damage repair at the repetitive sequences is the most plausible hypothesis explaining mtDNA deletion formation (21) (22) (23) (24) . This strongly suggests that mtDNA deletion formation is catalysed by ROS-induced DNA damage in repeated sequences.
Large mtDNA deletions are the most frequently observed mutations in mitochondrial disorders, cancer and aged tissues (reviewed in (21) ). Among large mtDNA deletions, the 4977-bp deletion (mtDNA CD4977 ) is particularly frequent. Numerous studies have shown that this deletion is proportional to the accumulation of UV-induced oxidative stress in the skin (25) (26) (27) (28) (29) (30) (31) (32) . Similarly to the skin, the eyes are exposed to both endogenous and exogenous oxidative stress. We recently showed that the incidence of mtDNA CD4977 in the cornea, iris and retina correlates with UV penetrance in the human eye but not with blue light (33) . This result suggests that UV-induced oxidative stress plays a role in the appearance of this mutation in the eye. We have observed that the mtDNA CD4977 accumulates with age in the corneal stroma, the layer conferring rigidity and transparency to the cornea, thus suggesting a role of this deletion in corneal ageing manifestations such as corneal stiffening and clouding (33) (34) (35) . Taken together, these observations made in the skin and in the eye suggest that UV light is the most important source of oxidative damage involved in the mtDNA CD4977 formation.
Another important mtDNA mutation is the 3895-bp deletion (mtDNA 3895 ). This deletion, occurring between positions 547 and 4443, has been originally described in diseased muscles (36) and associated with Kearns-Sayre syndrome and chronic progressive external ophthalmoplegia (37) . Almost a decade after its first observation in muscular diseases, the mtDNA 3895 incidence was investigated in skin. As for the mtDNA CD4977 , it has been shown that the mtDNA 3895 accumulates with age in sun-exposed skin and that UV light catalyses the appearance of this deletion in skin cells via the generation of ROS (38-41).
Furthermore, the mtDNA 3895 has been proposed as a biomarker of sunlight exposure in human skin (39, 40) . Given that the eye is exposed both to light-induced exogenous oxidative stress and, as a part of the neural system, to high endogenous oxidative stress, it was intuitive to survey the presence of the mtDNA 3895 in this organ. In the present study, using a sensitive TaqMan Q-PCR technique (39), we quantified the mtDNA 3895 occurrence in different human ocular structures including the cornea, the iris and the retina. Similarly to the mtDNA CD4977 , we found that the mtDNA 3895 accumulates with age in the corneal stroma. Moreover, in contrast to the mtDNA CD4977 , we show that the mtDNA 3895 is concentrated in the macular retina. To our knowledge, the mtDNA 3895 is the first mtDNA mutation shown to accumulate in the macular region of the retina.
Materials and methods
All experiments performed in this study were conducted in accordance with our institution's guidelines and the Declaration of Helsinki. The research protocols received approval by the Centre Hospitalier Affilié Universitaire de Québec (CHA) institutional committee for the protection of human subjects.
Human eye structures isolation and DNA purification
We used 47 human eyes from 7-to 94-year-old post-mortem donors (provided by La Banque d'Yeux du Centre Universitaire d'Ophtalmologie, Québec, Canada) unsuitable for transplantation and without overt mitochondrial diseases. Transplantation exclusion criteria are based on tissue quality criteria (e.g. scars). In presence of family history, genetic disease or virus (e.g. hepatitis, AIDS), the eyes were not enucleated and were thus unavailable for research purpose. All patients but the 7-year-old subject died from classical 'ageing' diseases such as cancer, pneumonia or heart failure. The eyes were removed no later than 1 h after death. They were dissected or frozen at −80°C for later dissection immediately upon reception, 24-48 h after enucleation. The cornea, iris and neural retina were dissected from whole ocular globes and then washed in 1× phosphate-buffered saline. In order to isolate the epithelium, stroma and endothelium, the corneas were incubated in HEPES buffer (0.01 M HEPES, pH 7.45; 0.142 M NaCl, 6.7 mM KCl and 1 mM CaCl 2 ) containing 2 mg/ml dispase II (Roche Applied Science) for 18 h at 4°C. The epithelium and the endothelium were then mechanically separated from the stroma under a dissecting microscope (42) . The three corneal structures were then washed in 1× phosphate-buffered saline. Isolation of the retinal pigment epithelium (RPE) was achieved by incubating the posterior eye with HEPES buffer containing 2 mg/ml dispase II for 45 min at 37°C. The RPE was then mechanically isolated from the choroid and then washed in 1× phosphate-buffered saline.
For all ocular structures, total DNA including mitochondrial and nuclear DNA, was isolated using the DNeasy Blood and Tissue Kit according to the manufacturer's protocol with an RNase treatment (Qiagen). DNA extracted from the neural retina, RPE and iris contains melanin that interferes with PCR. We thus further purified DNA from those ocular structures using MicroBiospin 6 chromatography columns (Bio-Rad Laboratories) to remove any trace of melanin. mtDNA 3895 level analysis by PCR mtDNA 3895 and total mtDNA levels were measured using a Rotor-Gene Q real-time thermocycler (Qiagen). PCR amplifications were performed with previously published primers designed to amplify mtDNA 3895 and total mtDNA and the quantification was achieved using TaqMan probes ( Figure 1 and Table I ) (39) . The mtDNA 3895 primer set allows PCR amplification only when the mtDNA molecule contains the 3895-bp deletion. The amplification using those primers was done with 20 ng of total DNA. The primer set for total mtDNA amplifies a region without previously reported mtDNA deletion. Those primers are located in the 7S DNA coding region. A standard curve (20, 10, 1, 0.1, 0.01 and 0.005 ng total DNA/reaction) was performed with those primers and the TaqMan probe detecting total mtDNA. For each sample, the amplification level of mtDNA 3895 primers was compared with the standard curve and a ratio of 'mtDNA molecules containing the 3895-bp deletion' to 'total mtDNA molecules' (mtDNA 3895 /mtDNA) was derived. Samples with a Ct over 35 amplification cycles in our conditions were considered negative for the presence of mtDNA 3895 . PCRs were performed in 20 µl containing 1× TaqMan Universal PCR standard Mix (Roche Applied Science), 7.5 µM each primer and 2.5 µM TaqMan probe (Table I) . Q-PCR cycling conditions were as follows: 2 min at 50°C, 10 min at 95°C followed by 40 cycles of 15 s at 95°C and 60 s at 56°C. 
Statistical analysis
Quantification data were reported on KaleidaGraph v4.0 software to
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3895 levels were quantitatively evaluated by Q-PCR in different human eye structures using previously published TaqMan probes and primers spanning both sides of the deletion (39) (Figure 1 and Table I ). Those primers are designed in such a way that our short Q-PCR extension time only allows amplification of the deleted mtDNA molecule. Total mtDNA molecules were amplified with primers located in a control region without reported deletion and its level was detected using a TaqMan probe. Using the Q-PCR data, we derived the 'mtDNA molecules containing the 3895-bp deletion/total mtDNA molecules' ratio. This strategy corrects for the variation of mtDNA copy number between cells.
The mtDNA 3895 occurrence in the human eye We quantified the mtDNA 3895 /mtDNA ratio in the cornea, iris and retina from 10 subjects with a median age of 73.5. We observed a significantly higher mtDNA 3895 level in both the . The primer set Y1/Y2 is designed to detect total mtDNA by amplifying an mtDNA region without previously reported deletion. X3 and Y3 are TaqMan probes allowing quantitative detection of the mtDNA 3895 and the total mtDNA, respectively. X3 probe only binds to mtDNA 3895 molecules.
cornea and the neural retina compared with the iris (P < 0.002) with median values of 0.062%, 0.034% and 0.006%, respectively ( Figure 2 ). No statistical difference was found between the cornea and the neural retina.
The mtDNA 3895 accumulates with age in the human corneal stroma Since a high mtDNA 3895 incidence is found in the cornea, we further analysed its formation in the different layers constituting that structure (i.e. the epithelium, stroma and endothelium). Corneas from eight subjects with a median age of 68 years were used ( Figure 3 ). We found that the corneal stroma contains the highest level of mtDNA 3895 in comparison with the epithelium and the endothelium (P < 0.005) with median values of 0.054%, 0.015% and 0.022%, respectively. We then verified if the mtDNA 3895 accumulates with age in the corneal stroma by evaluating the mtDNA 3895 /mtDNA ratio in this layer from 24 subjects (Figure 4) . Because the eyes come from post-mortem donors, eyes from young subjects are rarely obtained. In fact, only one subject below 50 years old (a 7-year-old subject) was tested and the mtDNA 3895 level was undetectable in the corneal stroma of this particular donor. The other samples were divided in two arbitrary groups ranging from 50 to 70 years old exclusively and from 70 to 95 years old inclusively. As can be seen in Figure 4 , the occurrence of mtDNA 3895 is higher in the older group than in the younger group with mtDNA 3895 /mtDNA median ratios of 0.061% and 0.030%, respectively. The difference between the two groups Fig. 2 . The mtDNA 3895 analysis in different ocular structures. The cornea, iris and neural retina were dissected and the total DNA was extracted from each structure. The mtDNA 3895 and total mtDNA were then detected by Q-PCR. mtDNA 3895 /total mtDNA ratio was evaluated by Q-PCR in the neural retina, iris and cornea of 10 human subjects with a median age of 73.5. The results depicted in the box plot clearly show a higher mtDNA 3895 levels in both the cornea (0.062%) and the neural retina (0.034%) when compared with the iris (0.006%). According to the Wilcoxon test, the mtDNA 3895 /total mtDNA ratio was significantly different between the cornea and the iris and between the neural retina and the iris (*P < 0.002) but not between the neural retina and the cornea. Fig. 3 . Within the cornea, the mtDNA 3895 is concentrated in the stroma. The mtDNA 3895 /total mtDNA ratio was evaluated by Q-PCR in the corneal epithelium, stroma and endothelium of eight human subjects with a median age of 68. Corneas were dissected and their layers were separated by a dispase II treatment. As depicted in the box plot, the mtDNA 3895 is concentrated in the stroma (0.054%) when compared with the epithelium (0.015%) and the endothelium (0.022%). The mtDNA 3895 /total mtDNA ratio was significantly different between the stroma and both the epithelium and endothelium (*P < 0.005). is significant (P < 0.006), indicating a correlation between mtDNA 3895 and human ageing in the corneal stroma ( Figure 4 ).
The mtDNA 3895 in human neural retina and RPE Since the mtDNA
3895 is present at a similarly high level in the cornea and in the neural retina, we further investigated its occurrence in the retina. This was done using neural retina from six human subjects with a median age of 61 years. We found that the macular region of the neural retina contains a significantly (P < 0.04) higher mtDNA 3895 level compared with the peripheral region (i.e., 0.048% and 0.026% for the macular and peripheral neural retina, respectively; Figure 5 ). The retina is composed of several layers of nerve cells (neural retina) and the RPE. The RPE plays a major role in vision and is intimately connected with the photoreceptors of the neural retina. We thus also investigated the mtDNA 3895 occurrence in the peripheral and macular region of the RPE. Using RPE of seven human donors with a median age of 85 years, we show that the macular region of the RPE contains a significantly (P < 0.04) higher mtDNA 3895 level than the peripheral region ( Figure 5 ).
Discussion
The mtDNA 3895 in the cornea, iris and retina Previous studies have shown that UV light catalyses mtDNA 3895 formation in the human skin (38-41). Moreover, it has been demonstrated that antioxidants prevent mtDNA 3895 induction in UV-exposed skin cells (41) . Those evidences strongly suggest that oxidatively generated DNA damage by UV light are the main cause of mtDNA 3895 formation. Here, we observed a high mtDNA 3895 concentration in the cornea, the most anterior part of the eye. More precisely, the mtDNA 3895 levels are 0.062% and 0.006% in the cornea and the iris, respectively. These results are consistent with the data supporting that UV light catalyses the occurrence of this deletion. Indeed, the cornea absorbs a large portion of UV wavelengths (43) (44) (45) . In consequence, the amount of oxidatively generated DNA damage induced by UV light is suspected to be high in this ocular structure. The iris is also exposed to UV light but to a lesser extent than the cornea (43) (44) (45) . Because the mtDNA 3895 levels follow the UV penetrance in the cornea and the iris, a mechanism involving UV-induced oxidative stress is suspected to cause this deletion in the anterior part of the eye. On the other hand, mtDNA 3895 level comparable to what has been found in the cornea is observed in the neural retina (Figure 2 ). Since UV wavelengths are completely filtered out by the adult cornea, this result is in contradiction with an exclusive role of UV light in the induction of the mtDNA 3895 in the human eye. is concentrated in the macular region of the neural retina (0.048%) when compared with the periphery (0.026%). For the RPE, the mtDNA 3895 /total mtDNA ratio was evaluated by Q-PCR in the RPE of seven human subjects with a median age of 85. As for the neural retina, the mtDNA 3895 level in RPE is concentrated in the macular region (0.036%) compared with the peripheral (0.014%). The mtDNA 3895 /total mtDNA ratio was significantly different between the macular region and the periphery of both the neural retina and the RPE (*P < 0.04).
We have previously analysed the occurrence of another mtDNA deletion (the mtDNA CD4977 ) in the human eye (33 , the mtDNA 3895 is 10 times more concentrated in the cornea compared with the iris. On the other hand, we reported 40-fold less mtDNA CD4977 deletion in the retina when compared with the cornea, whereas the mtDNA 3895 levels are similar in those structures. This suggests that the induction mechanism of the mtDNA 3895 and the mtDNA CD4977 is different in the retina.
The mtDNA 3895 is concentrated in the human corneal stroma According to the hypothesis that sunlight is involved in mtDNA 3895 formation, it could be expected that, as the most anterior part of the cornea, the epithelium should contain the highest levels of the mtDNA 3895 followed by the stroma and the endothelium. Here, we report that the mtDNA 3895 is concentrated in the stroma, with levels 3.6 and 2.5 times higher than in the epithelium and the endothelium, respectively (Figure 3) . We have previously observed that the mtDNA CD4977 is also concentrated in the corneal stroma, but to a much greater extent (i.e. 175 and 65 times higher in the stroma than in the epithelium and the endothelium, respectively). These results are not inconsistent with the involvement of sunlight-induced oxidation in the generation of both the mtDNA 3895 and the mtDNA CD4977 . In fact, the high corneal epithelial cells turnover might protect them from accumulating mtDNA deletions. This is consistent with the higher susceptibility of quiescent corneal stroma cells (keratocytes) to UV-induced mtDNA deletions. However, this is incoherent with the low level of mtDNA deletions found in the corneal endothelium, where cells are also in a quiescent state and exposed to sunlight's UV rays (43) (44) (45) . Another mechanism that may prevent mtDNA deletion formation in the corneal epithelium and endothelium is the presence of antioxidants [i.e. ascorbate, superoxide dismutase (SOD) and glutathione peroxidase 1 (GPx)] that can prevent light-induced oxidation. Those are either absent or present at a much lower concentration in the corneal stroma compared with the corneal epithelium and endothelium (46) (47) (48) (49) (50) (51) .
The mtDNA 3895 and corneal ageing In human skin, the mtDNA 3895 has been found to accumulate with age in sun-exposed skin and has thus been proposed as a biomarker for sunlight exposure (38) (39) (40) . Our evaluation of the mtDNA 3895 in human eye clearly shows that this deletion accumulates with age in the corneal stroma ( Figure 4 ) and that sunlight is most likely involved in this process ( Figures  2 and 3) . In a previous work, we have also observed agerelated mtDNA CD4977 accumulation in the corneal stroma (33) . It has also been reported that mtDNA deletion accumulation catalyses skin collagen disorganisation and degradation (52, 53) . Collagen is the main constituent of the corneal stroma where the highest amount of mtDNA deletion has been found ((33); Figure 3 ). Stromal collagen plays a major role in the rigidity and transparency properties of the cornea. Corneal stiffening and clouding are observed with age and it is speculated that mtDNA deletion accumulation is responsible for some of those ageing phenotypes (34, 35) .
The mtDNA 3895 in the retina Exogenous and endogenous elements make the retina an environment with high oxidative content. Because of its function, the retina is exposed to a large amount of visible light, including blue oxidising light (43, 45) . The retina contains a large number of photosensitising chromophores (e.g. vitamin A metabolites, lipofuscin, melanin, flavins, porphyrins and carotenoids) that generate ROS when excited by an appropriate wavelength of light (reviewed in (54)). Cellular chromophores are mainly excited by UVA (320-400 nm) and blue light wavelengths (400-500 nm). For example, lipofuscin is highly concentrated in the RPE and has an absorption peak at 430 nm. The absorption of blue light by lipofuscin leads to the formation of singlet oxygen, superoxide anion and hydrogen peroxide (55) (56) (57) . Also, the mitochondrial OXPHOS process generating ROS is more important in cells with a high energetic activity level, such as neurons and muscle cells. Since the retina contains photosensitive neural sensory cells (cones and rods), the OXPHOS process generates substantial mitochondrial ROS levels in those cells (58) (59) (60) (61) (62) . In fact, the retina is one of the highest oxygen-consuming tissues in the human body (63) . The mtDNA 3895 level comparable to what we found in the cornea is observed in the neural retina ( Figure 2 ).
The mtDNA 3895 is concentrated in the macula of human retina In both the neural retina and the RPE, the mtDNA 3895 is significantly higher in the macular when compared with the peripheral region ( Figure 5 ). The macular region is responsible for the central high-resolution vision. Consequently, light entering the eye is focused on the macula. We hypothesise that the high macular mtDNA 3895 concentration is a consequence of the environmental light-induced oxidation, presumably from the blue-light wavelengths. This is consistent with the observation that blue-light exposure harms mitochondrial respiratory activity and damages mtDNA of skin epithelial cells (64) . Taken together, our previously published data (33) and the results presented here suggest that the mtDNA CD4977 is catalysed by UV wavelengths that are blocked by the anterior part of the eye, whereas the mtDNA 3895 is catalysed by the UV and the blue light wavelengths that affect both the cornea and the macular retina.
The mtDNA 3895 and age-related macular degeneration Age-related macular degeneration (AMD) is the leading cause of vision loss in adults over 50 years old. It affects 10% of patients between 65 and 75 years old and 30% of patients over 75 years old. There are number of evidences strongly supporting that mitochondrial dysfunction is an important factor underlying the development of AMD. The mtDNA CD4977 has been shown to accumulate with age in the RPE (65,66) but those studies have either not analysed or failed to demonstrate that this deletion is concentrated in the macular region. Our results show 2.6 times more mtDNA 3895 in the macular RPE when compared with the peripheral (Figure 5 ). The number of mitochondria decreases with age in RPE cells and this phenomenon is accentuated in AMD patients (67) . It is suspected that this decrease leads to a compensation mechanism in which each mitochondrion needs to produce more adenosine triphosphate by the OXPHOS process, resulting in more generated ROS, thus feeding the 'vicious cycle' (Figure 6 ). When exposed to high levels of ROS, there is a preferential damage to mtDNA and slow DNA repair in RPE cells (68) (69) (70) . Our results concerning the mtDNA 3895 bring additional evidence supporting that mitochondrial dysfunction may be an important factor involved in AMD. However, at this point, it is hazardous to speculate about the implication of mtDNA 3895 deletion in the aetiology of AMD. The clinical expression of a pathogenic mtDNA mutation is determined by the relative proportion of normal and mutant mtDNA genomes in the tissue. A minimal critical level of mutant DNA is required to cause mitochondrial dysfunction resulting in disease. This critical level, called the threshold, is unknown for the mtDNA 3895 deletion. Therefore, it is impossible to predict whether the measured amount of deletion in the macular region of the retina is likely to be responsible for the AMD. Nonetheless, to our knowledge, this is the first mtDNA mutation showing accumulation in the macular region of the retina. The impact of the mtDNA 3895 deletion on mitochondrial functions needs further investigation but it can be speculated that the accumulation of this deletion, affecting at least nine proteins and tRNA coding sequences, is perturbing the mitochondrial respiratory chain, thereby participating in the amplification of a 'vicious cycle' of ROS generation (71) (Figure 6 ).
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This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to P.J.R. P.J.R is a research scholar from the Fonds de recherche en santé du Québec -Santé FRQ-S. Fig. 6 . Model of mtDNA deletion formation from endogenous and exogenous source of ROS and the consequences of those deletions on human skin and eye. ROS originating from endogenous (OXPHOS) and exogenous sources (UV and blue light) lead to the formation of oxidatively generated mtDNA damage that catalyse the induction of mitochondrial deletions, such as the mtDNA 3895 . Accumulation of mtDNA deletions causes the loss of coding proteins and tRNA resulting in a deficient OXPHOS pathway that lead the formation of more ROS, feeding the known 'vicious cycle'. The accumulation of mtDNA deletions in the skin is responsible for some of the photoageing phenotypes such as wrinkles and loss of elasticity. In the eye, mtDNA deletions are suspected to be responsible for ageing phenotypes such as clouding and stiffening in the cornea and AMD in the retina.
